Login / Signup

HMGB1 as a potential new marker of disease activity in patients with multiple sclerosis.

Maria BucovaBeata MajernikovaVladimira DurmanovaDaniela CudrakovaKarin GmitterovaIveta LisaEleonora KlimovaKristina KluckovaMilan Buc
Published in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2019)
Our results suggest chronic low-grade inflammation in MS patients that correlates with clinical conditions of MS patients, and for HMGB1 as a possible target molecule in future therapy.
Keyphrases